Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion dollar deal that brings a portfolio of products marketed …

… acquisition of Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC), a biotechnology … to the Crown family. This acquisition strengthens our leadership position and … . About Revance Revance is a biotechnology company setting the new standard …

… $289 million, the post-merger company will have enough money … in uveitis, forcing the biotech to discontinue its development. … 2023. Alumis’ original, pre-merger pipeline includes ESK-001, an … From Acelyrin, the post-merger Alumis pipeiline will also feature …

… Acelyrin are merging, the biotechnology companies said Thursday afternoon, … operating into 2027.   The merged entity will continue to … Insight: Prior to the merger, Acelyrin and Alumis were struggling … multiple sclerosis as well.   The merger, then, is a “ …

… is another Vancouver-based biotech company that has enjoyed … invested so heavily in biotechnology companies during the pandemic … be when there are acquisitions, and that can mean … workforce. The biotechnology trade journal Fierce Biotech described the Sqz …

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026 Evaluation …

… position in two prospective biotech stocks. Cathie Wood continues … increased its stake in 3 biotech companies — Illumina Inc (NASDAQ … The acquisitions are all the more significant because biotech is usually … ). All in all, the acquisitions cost a total of $9 …

… tumors.   Another billion-dollar acquisition that took place last month … Therapeutics acquisition last month, Eli Lilly announced its partnership with American biotech … 150 million in milestone payments. Biotech partnerships: accelerating drug discovery And …

… Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International … ., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine … market share, latest development plan, merger, and acquisition information, etc. Chapter 4 …